Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT107 Add-On in Resistant Hepatitis C (ECLIPSE 2)
NCT01025297Phase 2Unknown
- Sponsor
- Cytheris SA
- Start
- Jul 2008
- Primary completion
- Dec 2012
- Modality
- Cytokines & Interferons
- Countries
- 3
01
Overview
A Phase 2 trial of recombinant human interleukin-7 in hepatitis C (HCV), sponsored by Cytheris SA. Status: unknown.
02
Drugs
recombinant human interleukin-7
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01025297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025297.